Skip to main content Accessibility help

As of 5 December 2023, Expert Reviews in Molecular Medicine has moved to a Gold Open Access publishing model. All accepted articles from this date will be published with a Creative Commons licence and will be subject to an Article Processing Charge (see the journal’s Open Access Options page for available licence options). Many corresponding authors will have their APC covered by a transformative agreement; check here to see if your institution is covered. Any author without funding or not covered by a transformative agreement can apply for a waiver.

Please see the journal's Open Access Options page for instructions on how to request an APC waiver. 

See this FAQ for more information.

    • You have access: full
    • Open access
  • ISSN: 1462-3994 (Online)
Editor-in-Chief: Professor Nicola Curtin
Editorial Board
Expert Reviews in Molecular Medicine is a gold open access journal featuring authoritative and timely reviews on all aspects of molecular medicine. Review articles cover current and emerging understanding of the molecular mechanisms underpinning human health and disease, and molecular aspects of the approaches used to diagnose and treat them. They may critically evaluate laboratory or in silico studies, studies on patient samples and molecular aspects of clinical diagnostics or therapy. The journal's focus is on translation from molecular science to clinical studies and is not constrained to any single system or disease. We particularly welcome articles spanning more than one of the themes below.Overarching Themes:
Molecular mechanisms of disease, including hereditary disordersMolecular aspects of infection, immunity and inflammationDiagnostic, prognostic and predictive molecular biomarkersMolecular mechanisms of all classes of therapeutic agents, including novel and repurposed drugs, biologics, immunotherapeuticsNovel molecular technologiesBioinformatics.Within these themes topics may be disease-specific. While we welcome papers covering all traditional specialist disease areas, we are also extremely interested in general cross cutting areas, including life-course diseases (in utero to ageing).

Latest articles

Featured content